Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

NCT05011266 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Opioid-use Disorder

Interventions

DRUG: Buprenorphine/naloxone
DRUG: Placebo

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]